Key Takeaways
- On April 13, 2026, Texas Attorney General Ken Paxton launched a civil investigation targeting Lululemon
- The probe examines potential PFAS contamination in the company’s activewear products
- Shares of LULU declined more than 3% following the announcement
- Investigators will scrutinize the company’s Restricted Substances List, quality testing procedures, and supplier networks
- This investigation compounds existing challenges including weakening revenue and leadership changes
The athletic apparel brand took a hit on Monday after Texas Attorney General Ken Paxton announced a Civil Investigative Demand directed at Lululemon, triggering a stock decline exceeding 3%.
Lululemon Athletica Inc., LULU
The inquiry centers on potential consumer deception regarding the health and safety characteristics of the company’s merchandise.
Specifically, investigators are looking into whether Lululemon’s apparel contains PFAS — commonly referred to as “forever chemicals” — which would contradict the brand’s carefully cultivated image.
Lululemon fell in New York trading Monday after the Texas attorney general said his office is investigating for the presence of so-called “forever chemicals,” which have been linked to health problems, in the yogawear brand’s apparel https://t.co/NaijH4MOmw
— Bloomberg (@business) April 13, 2026
Research has connected PFAS exposure to serious health issues including hormonal imbalances, reproductive problems, and various cancers.
“Texans deserve transparency when making wellness decisions for their households,” Paxton declared in his official statement. “No company will be permitted to market potentially hazardous, chemical-laden products at inflated prices while falsely claiming to promote health and environmental responsibility.”
This language is particularly damaging for Lululemon, which has positioned itself as a champion of wellness and eco-friendly practices, making these allegations strike at the heart of its brand promise.
Scope of the Investigation
Texas authorities intend to examine Lululemon’s internal prohibited substances documentation, quality assurance testing methods, and vendor management systems.
Investigators aim to verify whether the retailer’s merchandise actually meets the safety benchmarks the company publicly promotes.
With fiscal 2025 revenues surpassing $11 billion, Lululemon has positioned itself as a luxury wellness-focused lifestyle company.
Mounting Challenges for the Athletic Brand
The timing of this investigation couldn’t be worse for the retailer.
Lululemon has been grappling with softening sales figures and declining share value as 2026 unfolds.
Additionally, the organization is navigating a chief executive transition while managing demands from activist shareholders.
Compounding these issues, company creator Chip Wilson has been vocal about his desire for board composition changes.
The Texas investigation represents yet another challenge in an increasingly difficult operating environment.
Analyst consensus currently rates LULU as a Hold, reflecting opinions from 20 Wall Street analysts surveyed over the past three months. The breakdown includes one Buy rating alongside 19 Hold recommendations.
The mean analyst price target stands at $179.53, suggesting potential upside of approximately 11.5% from present trading levels.
